|1.||Gillespie, Barbara E: 3 articles (05/2007 - 01/2002)|
|2.||Dowlen, Henry H: 3 articles (05/2007 - 01/2002)|
|3.||Oliver, Stephen P: 3 articles (05/2007 - 01/2002)|
|4.||Moorehead, Hugh: 3 articles (05/2007 - 01/2002)|
|5.||Johnson, David L: 3 articles (05/2007 - 01/2002)|
|6.||Ruegg, P L: 2 articles (09/2014 - 01/2007)|
|7.||Barkema, H W: 2 articles (04/2012 - 03/2012)|
|8.||Saini, V: 2 articles (04/2012 - 03/2012)|
|9.||Scholl, D T: 2 articles (04/2012 - 03/2012)|
|10.||McClure, J T: 2 articles (04/2012 - 03/2012)|
02/01/2005 - "These studies were conducted to evaluate the efficacy of daily intramammary infusions with 50 mg of pirlimycin hydrochloride for the treatment of subclinical mastitis. "
06/01/2009 - "Many target pathogens from cows with subclinical mastitis were eliminated without treatment, and treatment with pirlimycin did not improve the treatment success rate. "
06/01/2009 - "Cows with positive results for a California mastitis test (CMT) were assigned to receive 50 mg of pirlimycin via intramammary administration into each CMT-positive mammary gland every 24 hours for 2 consecutive days or no treatment. "
04/01/2012 - "Intramammary administration of pirlimycin for lactating cow mastitis treatment was associated with pirlimycin resistance as well (OR: 2.07). "
06/01/2009 - "To determine the association between results of in vitro antimicrobial susceptibility tests and outcomes in cows that received intramammary treatment with pirlimycin hydrochloride for subclinical mastitis associated with gram-positive pathogens. "
01/01/2002 - "Results of this study indicate that extended pirlimycin therapy was effective in eliminating intramammary infections caused by environmental streptococci and S. "
01/01/2003 - "uberis intramammary infections were eliminated in 58.1% of the infected quarters treated with the pirlimycin 2-day regimen, 68.8% for the 5-day regimen, and 80.0% for the 8-day regimen. "
01/01/2003 - "Efficacy of extended pirlimycin therapy for treatment of experimentally induced Streptococcus uberis intramammary infections in lactating dairy cattle."
01/01/2002 - "Efficacy of pirlimycin therapy against intramammary infections caused by environmental Streptococcus spp and S. "
01/01/2002 - "Fifty-one chronically infected lactating dairy cows were used to evaluate the efficacy of extended pirlimycin therapy regimens for treatment of intramammary infections by environmental Streptococcus spp and Staphylococcus aureus. "
05/01/1993 - "Pirlimycin is an analog of clindamycin that will be recommended for therapy of bovine mastitis. "
04/01/2012 - "Herd-level use of certain antimicrobials administered for mastitis treatment and control, such as intramammary penicillin and pirlimycin as well as systemically administered penicillin and florfenicol, was positively associated with antimicrobial resistance in bovine mastitis pathogens in the field conditions. "
01/01/2007 - "As known from other lincosamides and 16-membered macrolides, the antimicrobial agents pirlimycin, spiramycin and tylosin, which are frequently used for the therapy of bovine mastitis, cannot induce the expression of the resistance gene erm(C). "
|4.||Acquired Immunodeficiency Syndrome (AIDS)
01/01/2004 - "Summaries follow of the Committee's evaluations of toxicological and residue data on a variety of veterinary drugs: five antibacterial agents (cefuroxime, chloramphenicol, flumequine, lincomycin, pirlimycin), four insecticides (cyhalothrin, cypermethrin and alpha-cypermethrin, doramectin, phoxim), and two production aids (melengestrol acetate, ractopamine). "
|5.||Anti-Bacterial Agents (Antibiotics)
|7.||Veterinary Drugs (Veterinary Drug)